Acrivon Therapeutics Ownership | Who Owns Acrivon Therapeutics?

Acrivon Therapeutics Ownership Summary

Acrivon Therapeutics is owned by 36.95% institutional investors, 21.09% insiders, and 41.96% retail investors. Ra capital management is the largest institutional shareholder, holding 21.81% of ACRV shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 1.68% of its assets in Acrivon Therapeutics shares.

ACRV Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Acrivon Therapeutics	36.95%	21.09%	41.96%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	8.34M	21.81%	$16.93M
Perceptive advisors	5.36M	14.02%	$10.88M
Baker bros. advisors lp	22.81K	0.06%	$46.30K
Dafna capital management	-	-	-
Trexquant investment lp	-	-	-
Pale fire capital se	-	-	-
Corton capital	-	-	-
Russell investments group	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Perceptive advisors	5.36M	0.38%	$10.88M
Ra capital management	8.34M	0.28%	$16.93M
Baker bros. advisors lp	22.81K	0.00%	$46.30K
Dafna capital management	-	-	-
Trexquant investment lp	-	-	-
Pale fire capital se	-	-	-
Corton capital	-	-	-
Russell investments group	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	8.34M	0.28%	-
Perceptive advisors	5.36M	0.38%	-
Russell investments group	-	-	-223.00
Corton capital	-	-	-12.16K
Pale fire capital se	-	-	-15.23K

Top Sellers

Holder	Shares	% Assets	Change
Dafna capital management	-	-	-112.41K
Baker bros. advisors lp	22.81K	0.00%	-30.08K
Trexquant investment lp	-	-	-16.87K
Pale fire capital se	-	-	-15.23K
Corton capital	-	-	-12.16K

Sold Out

Holder	Change
Russell investments group	-223.00
Corton capital	-12.16K
Pale fire capital se	-15.23K
Trexquant investment lp	-16.87K
Dafna capital management	-112.41K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	4	-93.10%	14,129,412	-38.60%	36	1.01%	-	-100.00%	1	-92.86%
Dec 31, 2024	59	15.69%	23,249,551	1.26%	61	1.68%	31	29.17%	14	-
Sep 30, 2024	51	-	22,960,755	-2.09%	60	1.43%	24	-31.43%	14	133.33%
Jun 30, 2024	51	10.87%	23,451,878	53.83%	64	1.43%	35	45.83%	6	-33.33%
Mar 31, 2024	46	12.20%	15,245,531	-0.33%	67	1.44%	24	33.33%	9	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
HBM Healthcare Investments AG Ord	527.15K	1.68%	-39.51K
Vanguard Total Stock Mkt Idx Inv	412.43K	1.32%	-
Vanguard US Total Market Shares ETF	387.41K	1.24%	-
iShares Russell 2000 ETF	277.32K	0.88%	135.00
Vanguard Institutional Extnd Mkt Idx Tr	176.37K	0.56%	-
iShares Biotechnology ETF	134.85K	0.43%	-632.00
Fidelity Small Cap Index	116.96K	0.37%	-
iShares Russell 2000 Value ETF	109.17K	0.35%	-
A4Investments SICAV SIF ACCI IlanaA2EURH	84.78K	0.27%	30.72K
Fidelity Extended Market Index	75.31K	0.24%	979.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 01, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$400.51K
Apr 30, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$617.41K
Apr 29, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$352.50K
Apr 25, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$2.06M
Apr 28, 2025	PERCEPTIVE ADVISORS LLC	-	Sell	$335.84K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	5
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	1	-

ACRV Ownership FAQ

Who Owns Acrivon Therapeutics?

Acrivon Therapeutics shareholders are primarily institutional investors at 36.95%, followed by 21.09% insiders and 41.96% retail investors. The average institutional ownership in Acrivon Therapeutics's industry, Biotech Stocks , is 63.96%, which Acrivon Therapeutics falls below.

Who owns the most shares of Acrivon Therapeutics?

Acrivon Therapeutics’s largest shareholders are Ra capital management (8.34M shares, 21.81%), Perceptive advisors (5.36M shares, 14.02%), and Baker bros. advisors lp (22.81K shares, 0.06%). Together, they hold 35.89% of Acrivon Therapeutics’s total shares outstanding.

Does Blackrock own Acrivon Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Acrivon Therapeutics.

Who is Acrivon Therapeutics’s biggest shareholder by percentage of total assets invested?

Perceptive advisors is Acrivon Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.38% of its assets in 5.36M Acrivon Therapeutics shares, valued at 10.88M$.

Who is the top mutual fund holder of Acrivon Therapeutics shares?

HBM Healthcare Investments AG Ord is the top mutual fund holder of Acrivon Therapeutics shares, with 1.68% of its total shares outstanding invested in 527.15K Acrivon Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools